Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

Clinical trial NCT07486934 · RECRUITING

Trial details

NCT number: NCT07486934
Sponsor: Dyne Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myotonic Dystrophy Type 1 (DM1)DM1 Myotonic Dystrophy Steinert Disease Steinert

Start date: 2026-05-14
Primary completion: 2028-07-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.